Workflow
PLA
icon
Search documents
90万欧元“白菜价”!中国上市公司抄底成功!买到Pepper和Nao,未来将投入2800万欧元运营
机器人大讲堂· 2025-07-13 07:22
7月10日晚间, 巴黎 商业法院,一场关乎机器人界"元老"命运的拍卖落槌。 曾以萌萌哒Pepper和Nao机器人风靡全球的法国先驱Aldebaran,在经历了破产、裁员、多次转手的颠沛流 离后,其核心资产的最终归宿,竟被一家来自中国的 上市 公司以 "难以置信"的90万欧元(约合人民币7 5 0 万元)拿下! 买主是谁? 2012年,由于入不敷出, Aldebaran 陷入 颠沛的"卖身"之路, 先 被软银 1亿美元收购,后更名为软银机 器人欧洲;2022年又被德国联合机器人集团(URG)接手,并短暂改回Aldebaran之名。URG曾尝试推出酒 店机器人Plato,但未能止血。 在 世 界 关 注 的 目 光 中 , 当 天 夜 里 , 市 场 消 息 就 传 出 , 深 交 所 上 市 的 " 智 慧 口 岸 第 一 股 "—— 盛 视 科 技 (002990.SZ) 成功拍的 。 这笔被业内称为"抄底"的交易,不仅让盛视科技瞬间获得了全球知名的人形机器人品牌与技术遗产,更可能改 写全球服务 人形 机器人市场的格局! ▍ 到底买到了什么? 从公告来看, 盛 视科技 确实是 "白菜价"购得 了 核心资产: ...
X @TylerD 🧙‍♂️
TylerD 🧙‍♂️· 2025-07-13 00:01
RT Loxley (@Loxley_eth)Our first time running in-play predictions.Scaling from beta through szn 2 was a stack of work, but you can still expect more features and lines being developed every day.should we lean into more in-play predictions?? ...
X @Avi Chawla
Avi Chawla· 2025-07-12 18:56
RT Avi Chawla (@_avichawla)Finally, a browser automation framework for Agents that actually works in production (open-source)!Typical browser automation tools like Selenium or Playwright require you to hard-code automation. These are brittle since one change in the website can disrupt the full workflow.On the other hand, high-level Agents like OpenAI Operator can be unpredictable in production.Stagehand is an open-source framework that bridges the gap between:- brittle traditional automation like Playwright ...
X @Arkham
Arkham· 2025-07-12 17:23
Register for Arkham. One account gives you:- Intelligence Platform Access- Exchange Trading Account- $100 Signup Bonushttps://t.co/BfmF1ug60fEligibility varies by jurisdiction. Perps not available for trading in the US. ...
The Low Altitude Market Could Be Worth $9 Trillion by 2050, According to Morgan Stanley. This Cathie Wood Stock Is My Top Pick to Dominate the Opportunity (Hint: It's Not Archer Aviation).
The Motley Fool· 2025-07-12 17:00
Group 1: Low Altitude Market Overview - The low altitude market presents significant opportunities within the defense industry and vehicle manufacturing sectors [1][2] - Morgan Stanley estimates the low altitude market could reach a value of $9 trillion by 2050, driven primarily by electric vertical takeoff and landing (eVTOL) aircraft and drones [4] Group 2: Key Companies in the Low Altitude Market - Archer Aviation and Joby Aviation are prominent players in the eVTOL market, while Tesla may benefit from advancements in low altitude aircraft due to its battery technology [5] - Palantir Technologies is highlighted as a key stock in Cathie Wood's Ark Invest portfolio, with strong ties to the defense sector and partnerships with drone companies [9][10] Group 3: Palantir's Position and Potential - Palantir is well-positioned to leverage its software platforms in both commercial and government sectors as low altitude services become more digitized [13] - The company has established strategic relationships that enhance its role in the defense contracting space, particularly in relation to drone technology [9][10]
X @Arkham
Arkham· 2025-07-12 16:58
Register for Arkham. One account gives you:- Intelligence Platform Access- Exchange Trading Account- $100 Signup Bonushttps://t.co/KnL3m95FNNEligibility varies by jurisdiction. Perps not available for trading in the US. ...
X @Arkham
Arkham· 2025-07-12 14:16
Register for Arkham. One account gives you:- Intelligence Platform Access- Exchange Trading Account- $100 Signup Bonushttps://t.co/BfmF1ufyaHEligibility varies by jurisdiction. Perps not available for trading in the US. ...
Lisata Therapeutics and GATC advance AI-driven opioid use disorder therapy - ICYMI
Proactiveinvestors NA· 2025-07-12 13:43
Core Insights - Lisata Therapeutics is deepening its collaboration with GATC Health, leveraging complementary strengths in clinical and regulatory expertise alongside AI-powered drug discovery [1][2] - The partnership aims to develop opioid use disorder (OUD) candidates, addressing a significant unmet medical need in the U.S. [3][6] - The MAT platform from GATC Health enhances drug development efficiency by predicting drug performance and identifying potential failures early [4][5] Company Collaboration - The partnership has evolved due to the effective collaboration between Lisata's clinical experience and GATC's bioinformatics capabilities [2] - The focus on OUD as the first joint development target is due to the availability of high-quality addiction data and the identification of novel targets linked to OUD [6] Drug Development Process - Traditional drug development is inefficient, often requiring extensive testing; the MAT platform aims to streamline this process by using AI to prioritize promising candidates [4] - The MAT platform acts as a forecasting tool, allowing for informed decision-making and reducing resource waste [5] Market Potential - The OUD market represents a multibillion-dollar opportunity in North America, with potential for significant revenue through licensing and milestone payments if the drug is successful [9] - The collaboration model between AI firms and biotech companies is expected to become more common, as it allows for innovative approaches to drug development [10]
3 Beaten-Down Dividend Stocks for Patient Investors to Buy in July and Hold for Years to Come
The Motley Fool· 2025-07-12 11:45
Group 1: Watsco - Watsco's stock has increased by 991% over the last 20 years, with a 272% rise in the previous decade and a 154% increase over the last five years, although it has seen a 4% decline in the past year [5] - The current dividend yield for Watsco is 2.7%, but reinvesting dividends over the last 20 years would yield a total return of 2,020% [6] - Watsco is a leading player in the HVAC industry, consistently acquiring small distributors and integrating them to enhance sales and geographic reach [6][7] - The company utilizes technology to support HVAC contractors, improving operational performance and ensuring long-term growth prospects as demand for HVAC servicing remains strong [7][8] Group 2: Occidental Petroleum - Occidental Petroleum's stock has dropped about 29% over the past year, correlating with a 21.5% decline in oil prices [9][11] - Despite the stock decline, Occidental has shown strong performance with an 18.6% year-over-year increase in oil and gas production and generated $1.2 billion in free cash flow [12] - The company has maintained a conservative 20% payout ratio from 2020 to 2024, indicating a secure dividend despite lower energy prices [15] Group 3: Campbell's Company - Campbell's stock is currently at a 16-year low, primarily due to challenges in integrating acquisitions and generating high-margin sales growth [16][19] - The company has made significant acquisitions totaling $9.5 billion, which exceeds its current market cap of $9.3 billion, leading to concerns about overpayment [18] - Despite struggles, Campbell's generates substantial free cash flow that covers its 5.1% dividend yield, and its forward price-to-earnings ratio is significantly lower than its 10-year median [19][20]
OLO INVESTIGATION NOTICE: Olo Inc. Shareholders are Notified of the Upcoming $10.25 Olo Merger – Contact BFA Law about Your Rights (NYSE:OLO)
GlobeNewswire News Room· 2025-07-12 11:36
Core Viewpoint - Bleichmar Fonti & Auld LLP is investigating Olo Inc. and its leadership for potential breaches of fiduciary duties related to the company's pending acquisition by Thoma Bravo for $10.25 per share, valuing Olo at approximately $2 billion in equity [1][3][4]. Company Overview - Olo Inc. operates an open SaaS platform for restaurants, facilitating digital commerce operations including ordering, delivery, engagement, and payments [3]. - The company's stock is divided into Class A and Class B shares, with Class B shares having ten votes per share compared to one vote for Class A shares. As of December 31, 2024, directors and executive officers collectively owned approximately 82% of the voting power of Olo's outstanding capital stock [3]. Acquisition Details - On July 3, 2025, Olo announced a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction [3]. - The acquisition price of $10.25 per share represents a 65% premium over Olo's unaffected share price of $6.20 as of April 30, 2025, indicating a significant increase in shareholder value [3].